Telescope Innovations Corp. (CSE:TELI)

Canada flag Canada · Delayed Price · Currency is CAD
0.345
+0.025 (7.81%)
Dec 5, 2025, 3:50 PM EST
1.47%
Market Cap 29.41M
Revenue (ttm) 4.62M
Net Income (ttm) -2.36M
Shares Out 85.25M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 13,898
Average Volume 59,931
Open 0.330
Previous Close 0.320
Day's Range 0.330 - 0.345
52-Week Range 0.230 - 0.650
Beta 1.57
RSI 46.64
Earnings Date Dec 22, 2025

About Telescope Innovations

Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. The company has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. to develop a method for producing high-purity lithium sulfide. Telescope Innovations Corp. is based in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Henry Dubina
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol TELI
Full Company Profile

Financial Performance

In 2024, Telescope Innovations's revenue was 4.43 million, an increase of 56.80% compared to the previous year's 2.82 million. Losses were -1.32 million, 84.3% more than in 2023.

Financial Statements

News

There is no news available yet.